BE890477A - Quinolones, leurs procedes de preparation et composition therapeutique les contenant - Google Patents

Quinolones, leurs procedes de preparation et composition therapeutique les contenant Download PDF

Info

Publication number
BE890477A
BE890477A BE0/206048A BE206048A BE890477A BE 890477 A BE890477 A BE 890477A BE 0/206048 A BE0/206048 A BE 0/206048A BE 206048 A BE206048 A BE 206048A BE 890477 A BE890477 A BE 890477A
Authority
BE
Belgium
Prior art keywords
emi
compound
quinolone
general formula
new
Prior art date
Application number
BE0/206048A
Other languages
English (en)
French (fr)
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of BE890477A publication Critical patent/BE890477A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
BE0/206048A 1980-09-26 1981-09-24 Quinolones, leurs procedes de preparation et composition therapeutique les contenant BE890477A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031106 1980-09-26

Publications (1)

Publication Number Publication Date
BE890477A true BE890477A (fr) 1982-03-24

Family

ID=10516302

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206048A BE890477A (fr) 1980-09-26 1981-09-24 Quinolones, leurs procedes de preparation et composition therapeutique les contenant

Country Status (4)

Country Link
JP (1) JPS5785369A (de)
BE (1) BE890477A (de)
HU (1) HU184968B (de)
ZA (1) ZA816352B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03196382A (ja) * 1989-12-26 1991-08-27 Nec Home Electron Ltd 携帯型情報処理装置

Also Published As

Publication number Publication date
JPS6348268B2 (de) 1988-09-28
ZA816352B (en) 1982-09-29
JPS5785369A (en) 1982-05-28
HU184968B (en) 1984-11-28

Similar Documents

Publication Publication Date Title
EP0283390B1 (de) Thiazolderivate mit Aktivität auf das cholinergische System, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
EP0399856B1 (de) Pteridin-4 (3H)-onen, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
EP0535081A1 (de) Substituierte benzimidazole, verfahren zur herstellung und pharmazeutische verwendung
EP0389370A1 (de) 19-Nor, 3-keto-Steroide mit einer amino-substituierten Kette, Verfahren zu deren Herstellung, Zwischenprodukte und pharmazeutische Präparate davon
EP0217700A1 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und deren therapeutische Anwendung
EP0611766A1 (de) Polysubstituierte 2-Amidothiazole-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zusammenstellungen die sie enthalten und ihre Anwendung für die Bereitung eines Arzneimittels
EP0624575A1 (de) Substituierte Indole und diese enthaltende Arzneimittel
EP0205362B1 (de) Chinolylglycinamidderivate, Verfahren zu ihrer Herstellung und therapeutische Verwendung als Psychotrope
EP0162776B1 (de) Heterozyklische Derivate, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel brauchbar als Aldosereduktaseinhibitoren
EP0117771B1 (de) Imino-2-pyrrolidine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
EP0136198B1 (de) Triazolopyrimidinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung als Kardiotonika
CH650254A5 (fr) Quinolones, leurs procedes de preparation et compositions therapeutiques les contenant.
EP0172058B1 (de) Phenylnaphthyridine, Verfahren zu deren Herstellung, diese enthaltende Arzneimittel, insbesondere Antigeschwür
EP0017578B1 (de) 5-(2-Hydroxy-3-thiopropoxy)-chromon-2-carbonsäuren, ihre Salze und Ester, Verfahren zur Herstellung und Arzneimittel
EP0062580B1 (de) Imidazo(1,2-a)chinolinderivate
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
EP0196943B1 (de) 8-Thiotetrahydrochinoleinderivate und deren Salze
JP2794640B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
MC1186A1 (fr) Derives de quinazoline
EP0362006A1 (de) Chinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPH02275846A (ja) カルボン酸誘導体
EP0663903B1 (de) 1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel
EP0269841B1 (de) 1-Hydroxyalkylxanthine, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE BOOTS CY PLC

Effective date: 19910930